Britain's GSK and partner Vir Biotechnology said on November 12 their antibody-based Covid-19 drug was shown in a trial to work as well when given as...
Having sent 1.5 billion Covid-19 vaccines around the world on a not-for-profit basis, AstraZeneca says it’s time to move into “modest profitability.” While the priority is...
The EMA’s human medicines committee has recommended approval of Roche’s Ronapreve and Celltrion’s Regkirona for use in COVID-19, The post COVID antibodies from Roche, Celltrion backed...
AstraZeneca has said it plans to start making a small profit from sales of its COVID-19 vaccine Vaxzevria, The post AstraZeneca will make ‘modest’ profit from...
Check these penny stocks out for your watchlist in November The post Are These Penny Stocks Worth Being Bullish On? 3 to Watch appeared first on...
The US federal government has ordered another 1.4 million doses of Merck & Co and Ridgeback Biotherapeutics’ oral The post US buys another $1 billion-worth of...
In a groundbreaking study of people living with HIV, University of Alberta researchers found that elusive white blood cells called neutrophils play a role in impaired...
Novotech, a leading biotech specialist CRO in the Asia-Pacific region, is sponsoring the ChinaTrials13 conference and will have teams from Novotech’s China offices attending to support...
Roblox Corp (NYSE: RBLX) shares jumped 30% after hours on Monday after the company posted robust fiscal Q3 results thanks to demand surge with the easing...
Regeneron Pharmaceuticals Inc. said on November 8 a single dose of the company's antibody cocktail reduced the risk of contracting Covid-19 by 81.6 percent in a...
A single dose of the COVID-19 monoclonal antibody therapy developing Regeneron reduced the risk of contracting the virus The post One dose of Regeneron’s COVID antibody...
5 short squeeze penny stocks to buy for under $5. Are they worth the risk? The post 5 Short Squeeze Penny Stocks To Buy For Under...
Pfizer plans to seek Emergency Use Authorization (EUA) for an antiviral Covid-19 treatment following an interim analysis of Phase II/III data shown to be statistically and...
Recouping from a series of setbacks for its gene therapy business, bluebird bio successfully bisected itself earlier this week as part of a big rebrand around...
Merck & Co and Ridgeback’s oral antiviral molnupiravir has been approved in its first market – the UK The post UK first to authorise Merck/Ridgeback’s COVID...
A real-world study of digital therapeutic (DTx) for opioid use disorder has found that patient show used it The post Digital therapeutic cuts opioid use disorder...
Rocketing sales of COVID-19 vaccine Comirnaty have allowed Pfizer to raise its full-year forecasts for the shot once The post Pfizer’s COVID jab sales swell again,...
Eli Lilly said on Nov. 2 that the U.S. government bought 614,000 additional doses of the company's Covid-19 antibody therapy for $1.29 billion.
Moderna has always been thinking about how mRNA could transform the gene editing space, according to Eric Huang. In fact, they looked at it about a...
Traditional treatment for broken ribs often centers on rest, time, and pain management, but what has become evident in recent years is that such passive treatment...
Therapeutics for depression, schizophrenia, and other neuropsychiatric disorders are targeting inflammation, stimulating neurogenesis, and taking cues from biomarkers. The post Neuropsychiatric Drug Developers Show a Renewed...
In emulation of computer science, synthetic biology is using “integrated circuits” and “logic boards” to speed the development of powerful therapeutic applications. The post Synthetic Biology...
Could these biotech stocks be top buys as investors digest the latest earnings figures? The post Best Stocks To Buy This Week? 3 Biotech Names To...
Welcome back to This Week in Apps, the weekly TechCrunch series that recaps the latest in mobile OS news, mobile applications and the overall app economy. The app...
On Oct. 8, California became the first state to require Ethnic Studies courses for students in order to graduate from high school. All California high schools...
COVID-19: Moderna Gets Its Miracle Authored by Whitney Webb via Unlimited Hangout, COVID-19 erased the regulatory and trial-related hurdles that Moderna could never surmount before. Yet,...
John Maraganore The departure of a number of CEOs is the prevailing theme that kicks off this week’s installment: In a stunner, Alnylam CEO John Maraganore...
A generic pill has been shown to reduce hospitalisation rates in high-risk patients with early COVID-19, potentially offering The post Generic pill could be alternative to...
Take two recently-approved immunotherapies for triple negative breast cancer (TNBC), put them together, and what do you get? The post Gilead tags Merck for first-line triple...
Texas A&M University Science Center, MD Anderson Cancer Center, and Pulmotect report that the drug PUL-042 appears to work against COVID-19 and other respiratory infections.